Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Feb 6, 2019

Total Value ($000): $1,259,627

Holdings (23)

INGN INOGEN INC 68.8%

Value ($000) $866,460 Shares 3,549,320 Est. Cost $17.78 Unrealized +1200.5%

GKOS GLAUKOS CORP 3.1%

Value ($000) $39,116 Shares 602,709 Est. Cost $30.48 Unrealized +61.0%

CRVS CORVUS PHARMACEUTICALS INC 3.0%

Value ($000) $37,928 Shares 4,420,516 Est. Cost $13.03 Unrealized -23.3%

— ACCELERON PHARMA INC 3.0%

Value ($000) $37,200 Shares 650,000 Est. Cost $27.65 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 2.2%

Value ($000) $27,373 Shares 3,100,000 Est. Cost $12.34 Unrealized -27.5%

— AERIE PHARMACEUTICALS INC 2.0%

Value ($000) $25,147 Shares 408,562 Est. Cost $63.41 Unrealized —

— DERMIRA INC 1.9%

Value ($000) $24,503 Shares 1,993,746 Est. Cost $30.14 Unrealized —

KIDS ORTHOPEDIATRICS CORP 1.9%

Value ($000) $23,983 Shares 654,549 Est. Cost $18.69 Unrealized +63.9%

— ENTASIS THERAPEUTICS HLDGS I 1.9%

Value ($000) $23,738 Shares 2,181,843 Est. Cost $10.88 Unrealized —

— MERUS N V 1.7%

Value ($000) $21,769 Shares 1,102,795 Est. Cost $7.99 Unrealized —

FOLD AMICUS THERAPEUTICS INC 1.6%

Value ($000) $19,923 Shares 1,647,870 Est. Cost $14.73 Unrealized -5.0%

STIM NEURONETICS INC 1.3%

Value ($000) $16,832 Shares 525,000 Est. Cost $30.40 Unrealized 0.0%

— SEASPINE HLDGS CORP 1.2%

Value ($000) $15,296 Shares 983,037 Est. Cost $10.44 Unrealized —

— MENLO THERAPEUTICS INC 1.1%

Value ($000) $14,148 Shares 1,436,313 Est. Cost $36.04 Unrealized —

— NABRIVA THERAPEUTICS PLC 1.0%

Value ($000) $12,700 Shares 4,703,720 Est. Cost $7.20 Unrealized —

GLPG GALAPAGOS NV 0.8%

Value ($000) $9,835 Shares 87,481 Est. Cost $112.42 Unrealized —

— VERONA PHARMA PLC 0.7%

Value ($000) $9,267 Shares 740,740 Est. Cost $11.66 Unrealized —

— INVUITY INC 0.7%

Value ($000) $8,953 Shares 1,209,854 Est. Cost $9.51 Unrealized —

— UNUM THERAPEUTICS INC 0.5%

Value ($000) $6,851 Shares 665,181 Est. Cost $47.61 Unrealized —

— WRIGHT MED GROUP N V 0.5%

Value ($000) $6,471 Shares 4,622,032 Est. Cost $1.25 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 0.3%

Value ($000) $4,298 Shares 150,000 Est. Cost $29.69 Unrealized 0.0%

— RA PHARMACEUTICALS INC 0.3%

Value ($000) $4,070 Shares 225,000 Est. Cost $15.19 Unrealized —

C CITIGROUP INC 0.3%

Value ($000) $3,766 Shares 52,500 Est. Cost $53.03 Unrealized +3.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$866,460	68.8%	$17.78	+1200.5%	—	45780L104
GKOS	GLAUKOS CORP	602,709	$39,116	3.1%	$30.48	+61.0%	—	377322102
CRVS	CORVUS PHARMACEUTICALS INC	4,420,516	$37,928	3.0%	$13.03	-23.3%	—	221015100
—	ACCELERON PHARMA INC	650,000	$37,200	3.0%	$27.65	—	—	00434H108
AKBA	AKEBIA THERAPEUTICS INC	3,100,000	$27,373	2.2%	$12.34	-27.5%	—	00972D105
—	AERIE PHARMACEUTICALS INC	408,562	$25,147	2.0%	$63.41	—	—	00771V108
—	DERMIRA INC	1,993,746	$24,503	1.9%	$30.14	—	—	24983L104
KIDS	ORTHOPEDIATRICS CORP	654,549	$23,983	1.9%	$18.69	+63.9%	—	68752L100
—	ENTASIS THERAPEUTICS HLDGS I	2,181,843	$23,738	1.9%	$10.88	—	—	293614103
—	MERUS N V	1,102,795	$21,769	1.7%	$7.99	—	—	N5749R100
FOLD	AMICUS THERAPEUTICS INC	1,647,870	$19,923	1.6%	$14.73	-5.0%	—	03152W109
STIM	NEURONETICS INC	525,000	$16,832	1.3%	$30.40	0.0%	—	64131A105
—	SEASPINE HLDGS CORP	983,037	$15,296	1.2%	$10.44	—	—	81255T108
—	MENLO THERAPEUTICS INC	1,436,313	$14,148	1.1%	$36.04	—	—	586858102
—	NABRIVA THERAPEUTICS PLC	4,703,720	$12,700	1.0%	$7.20	—	—	G63637105
GLPG	GALAPAGOS NV	87,481	$9,835	0.8%	$112.42	—	—	36315X101
—	VERONA PHARMA PLC	740,740	$9,267	0.7%	$11.66	—	—	925050106
—	INVUITY INC	1,209,854	$8,953	0.7%	$9.51	—	—	46187J205
—	UNUM THERAPEUTICS INC	665,181	$6,851	0.5%	$47.61	—	—	903214104
—	WRIGHT MED GROUP N V	4,622,032	$6,471	0.5%	$1.25	—	—	N96617126
CRNX	CRINETICS PHARMACEUTICALS IN	150,000	$4,298	0.3%	$29.69	0.0%	—	22663K107
—	RA PHARMACEUTICALS INC	225,000	$4,070	0.3%	$15.19	—	—	74933V108
C	CITIGROUP INC	52,500	$3,766	0.3%	$53.03	+3.3%	—	172967424